AllerPops

AllerPops

Early Stage

Liberate millions from allergies

Liberate millions from allergies

Overview

Raised to Date: Raised: $461,047

Total Commitments ($USD)

Platform

Wefunder

Start Date

12/15/2022

Close Date

07/30/2023

Min. Goal
$50,001
Max. Goal
$617,999
Min. Investment

$250

Security Type

Equity - Common

Series

Seed

SEC Filing Type

RegCF    Open SEC Filing

Price Per Share

$1.10

Early Bird Valuation

$7,815,000

Pre-Money Valuation

$9,769,000

Rolling Commitments ($USD)

Status
Funded
Reporting Date

08/05/2023

Days Remaining
Funded
% of Min. Goal
Funded
% of Max. Goal
Funded
Likelihood of Max
Funded
Avg. Daily Raise

$2,031

# of Investors

517

Momentum
Funded
Create a free account today to gain access to KingsCrowd analytics.
Year Founded

2016

Industry

Healthcare & Pharmaceuticals

Tech Sector

Medtech

Distribution Model

B2C

Margin

Medium

Capital Intensity

Low

Location

Los Alamos, New Mexico

Business Type

Growth

AllerPops, with a valuation of $9,769,000, is raising funds on Wefunder. It is providing a safe and natural support for a balanced immune system, with expertly formulated, FDA-approved ingredients to revolutionize allergy relief by correcting the root cause of allergic rhinitis. Current solutions are filled with chemicals and must be taken daily, where AllerPops users can get relief for months or even years. AllerPops has generated more than $230K in revenue during our product development and market tests. Cliff Han founded AllerPops in 2017. The current crowdfunding campaign has a minimum target of $50,000 and a maximum target of 617,998.64 . The campaign proceeds will be used for marketing, inventory and production development, FDA application and G & A.

Summary Profit and Loss Statement

FY 2022 FY 2021

Revenue

$44,889

$58,156

COGS

$9,903

$16,394

Tax

$0

$0

 

 

Net Income

$-555,037

$-353,340

Summary Balance Sheet

FY 2022 FY 2021

Cash

$34,880

$26,616

Accounts Receivable

$1,050

$300

Total Assets

$77,491

$181,458

Short-Term Debt

$224,046

$19,360

Long-Term Debt

$701,342

$291,962

Total Liabilities

$925,388

$311,322

Financials as of: 12/15/2022
Create a free account today to gain access to KingsCrowd analytics.

Raise History

Offering Name Close Date Platform Valuation/Cap Total Raised Security Type Status Reg Type
AllerPops 07/30/2023 Wefunder $9,769,000 $461,047 Equity - Common Funded RegCF
AllerPops 04/29/2021 Wefunder $7,500,000 $253,517 Equity - Preferred Funded RegCF
Create a free account today to gain access to KingsCrowd analytics.

Price per Share History

Note: Share prices shown in earlier rounds may not be indicative of any stock splits.

Valuation History

Revenue History

Note: Revenue data points reflect the latest of either the most recent fiscal year's financials, or updated revenues directly from the founder, at each raise's close date.

Employee History

Upgrade to gain access

Pay Monthly
Annually (Save 17%)

Edge

$25 /month
billed annually
Free portfolio tracking, data-driven ratings, AI analysis and reports
Plan Includes:
Everything in Free, plus
Company specific KingsCrowd ratings and analyst reports
Deal explorer and side-by-side comparison
Startup exit and failure tracking
Startup market filters and historical industry data
Advanced company search ( with ratings)
Get Edge Annual
Already a member? Log in here.

Ratings KingsCrowd Startup Rating Methodology Article

Blurred Ratings Bars Blurred Ratings Bars
Founders: enhance your startup's credibility on KingsCrowd. Create an account to claim this raise page.
Add to portfolio
AllerPops on Wefunder 2022
Platform: Wefunder
Security Type: Equity - Common
Valuation: $9,769,000
Price per Share: $1.10

Follow company

Follow AllerPops on Wefunder 2022

Buy AllerPops's Deal Report

Warning: according to the close date for this deal, AllerPops may no longer be accepting investments.

AllerPops Deal Report

Get KingsCrowd’s comprehensive report on AllerPops including:

  • How our proprietary algorithm rates their current capital raise (1-5 stars)
  • Detailed price, market, team, differentiators, performance, and risk ratings
  • Whether AllerPops is undervalued or overvalued
  • Scores on the founding team and key personnel's background and expertise

Buy the AllerPops deal report for only $10!

Email address:
Looking to buy more than one deal report? Get unlimited reports by upgrading to Edge